Expert Review of Vaccines
Volume 21, 2022 - Issue 3
Open access
3,905
Views
2
CrossRef citations to date
0
Altmetric
Original Research
Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18–25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016
Sarah Welbya GSK Vaccines Research and Development, GSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0003-3217-9490View further author information
Dominique Rosillona GSK Vaccines Research and Development, GSK, Wavre, Belgium
https://orcid.org/0000-0001-7230-1978View further author information
Yang Fengb Vaccines, Ningyang Group Co. Ltd on Behalf of GSK, Xiamen, China
https://orcid.org/0000-0003-4470-6411View further author information
Dorota Borysa GSK Vaccines Research and Development, GSK, Wavre, Belgium
https://orcid.org/0000-0001-9704-8462View further author information
Pages 407-413
|
Received 31 Aug 2021, Accepted 17 Dec 2021, Published online: 24 Jan 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.